CBO-421

N/A

Report date: 2023/11/17 14:39:20

Base Information

Drug NameCBO-421

Drug Alias NameCBO-212CD-421CBO-421

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of Action5'-nucleotidase inhibitors

Targets5'-nucleotidase

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesCidara Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesCidara Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A